跳至主要内容
临床试验/ITMCTR2024000108
ITMCTR2024000108尚未招募1 期

A cohort study of combined Chinese and Western medicine in the treatment of chronic kidney disease

Affiliated Hospital of Changchun University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
10 至 100(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria for CKD in the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines (2012) of the International Kidney Disease Organization. 2. = 10 years. 3. Be able to sign the informed consent form.

排除标准

  • 1. Diagnosis of one of the following diseases: polycystic kidney, human immunodeficiency virus infection, cirrhosis of the liver, multiple myeloma. 2. Conditions deemed severe or unsuitable for participation in the study by the attending physician. 3. Concurrently participate in other interventional clinical trials. 4. Unable to cooperate in completing the assessment of cognitive function or have comorbidities that interfere with the assessment of cognitive function such as intracranial tumors, traumatic brain injuries, visualization, and hearing pathology. 5. CKD caused by systemic inflammatory diseases or autoimmune diseases such as lupus erythematosus. 6. Pregnant or breastfeeding women. 7. Patients with hereditary renal disease.

研究者

相似试验